{"id":"https://openalex.org/W1994523841","doi":"https://doi.org/10.1097/fjc.0b013e31815ed0b9","title":"Trimerization of Apolipoprotein A-I Retards Plasma Clearance and Preserves Antiatherosclerotic Properties","display_name":"Trimerization of Apolipoprotein A-I Retards Plasma Clearance and Preserves Antiatherosclerotic Properties","publication_year":2008,"publication_date":"2008-02-01","ids":{"openalex":"https://openalex.org/W1994523841","doi":"https://doi.org/10.1097/fjc.0b013e31815ed0b9","mag":"1994523841","pmid":"https://pubmed.ncbi.nlm.nih.gov/18287885"},"language":"en","primary_location":{"id":"doi:10.1097/fjc.0b013e31815ed0b9","doi":"https://doi.org/10.1097/fjc.0b013e31815ed0b9","is_oa":false,"landing_page_url":"https://doi.org/10.1097/fjc.0b013e31815ed0b9","pdf_url":null,"source":{"id":"https://openalex.org/S61167191","display_name":"Journal of Cardiovascular Pharmacology","issn_l":"0160-2446","issn":["0160-2446","1533-4023"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cardiovascular Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031209046","display_name":"Jonas Heilskov Graversen","orcid":"https://orcid.org/0000-0001-7119-2108","observed_orcids":["https://orcid.org/0000-0001-7119-2108"]},"institutions":[{"id":"https://openalex.org/I204337017","display_name":"Aarhus University","ror":"https://ror.org/01aj84f44","country_code":"DK","type":"education","lineage":["https://openalex.org/I204337017"]}],"countries":["DK"],"is_corresponding":true,"raw_author_name":"Jonas Heilskov Graversen","raw_affiliation_strings":["ProteoPharma ApS and Department of Medical Biochemistry, University of Aarhus, Aarhus, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ProteoPharma ApS and Department of Medical Biochemistry, University of Aarhus, Aarhus, Denmark","institution_ids":["https://openalex.org/I204337017"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056110708","display_name":"Jacob Marsvin Laurberg","orcid":"https://orcid.org/0009-0009-1029-8297","observed_orcids":["https://orcid.org/0009-0009-1029-8297"]},"institutions":[{"id":"https://openalex.org/I2802335433","display_name":"Aarhus University Hospital","ror":"https://ror.org/040r8fr65","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802335433"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Jacob Marsvin Laurberg","raw_affiliation_strings":["Department of Cardiology, University Hospital (Skejby), Aarhus, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology, University Hospital (Skejby), Aarhus, Denmark","institution_ids":["https://openalex.org/I2802335433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102900173","display_name":"Mikkel Holmen Andersen","orcid":"https://orcid.org/0000-0002-6307-2541","observed_orcids":["https://orcid.org/0000-0002-6307-2541"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mikkel Holmen Andersen","raw_affiliation_strings":["Borean Pharma A/S, Aarhus, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Borean Pharma A/S, Aarhus, Denmark","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111483610","display_name":"Erling Falk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802335433","display_name":"Aarhus University Hospital","ror":"https://ror.org/040r8fr65","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802335433"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Erling Falk","raw_affiliation_strings":["Department of Cardiology, University Hospital (Skejby), Aarhus, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology, University Hospital (Skejby), Aarhus, Denmark","institution_ids":["https://openalex.org/I2802335433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087934172","display_name":"John D. Nieland","orcid":"https://orcid.org/0000-0001-7423-0122","observed_orcids":["https://orcid.org/0000-0001-7423-0122"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Nieland","raw_affiliation_strings":["Borean Pharma A/S, Aarhus, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Borean Pharma A/S, Aarhus, Denmark","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031304090","display_name":"Jesper Christensen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jesper Christensen","raw_affiliation_strings":["Borean Pharma A/S, Aarhus, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Borean Pharma A/S, Aarhus, Denmark","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056996958","display_name":"Michael Etzerodt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Etzerodt","raw_affiliation_strings":["Borean Pharma A/S, Aarhus, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Borean Pharma A/S, Aarhus, Denmark","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109980481","display_name":"Hans Christian Th\u00f8gersen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hans Christian Th\u00f8gersen","raw_affiliation_strings":["Borean Pharma A/S, Aarhus, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Borean Pharma A/S, Aarhus, Denmark","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075984061","display_name":"S\u00f8ren K. Moestrup","orcid":"https://orcid.org/0000-0003-3862-2107","observed_orcids":["https://orcid.org/0000-0003-3862-2107"]},"institutions":[{"id":"https://openalex.org/I204337017","display_name":"Aarhus University","ror":"https://ror.org/01aj84f44","country_code":"DK","type":"education","lineage":["https://openalex.org/I204337017"]}],"countries":["DK"],"is_corresponding":true,"raw_author_name":"S\u00f8ren Kragh Moestrup","raw_affiliation_strings":["ProteoPharma ApS and Department of Medical Biochemistry, University of Aarhus, Aarhus, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ProteoPharma ApS and Department of Medical Biochemistry, University of Aarhus, Aarhus, Denmark","institution_ids":["https://openalex.org/I204337017"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5031209046","https://openalex.org/A5075984061"],"corresponding_institution_ids":["https://openalex.org/I204337017"],"apc_list":null,"apc_paid":null,"fwci":0.9437,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.65552805,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"51","issue":"2","first_page":"170","last_page":"177"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12955","display_name":"Atherosclerosis and Cardiovascular Diseases","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/apolipoprotein-a-i","display_name":"apolipoprotein A-I","score":0.9980000257492065},{"id":"https://openalex.org/keywords/trimerization","display_name":"trimerization","score":0.6779999732971191},{"id":"https://openalex.org/keywords/tetranectin","display_name":"tetranectin","score":0.8510000109672546},{"id":"https://openalex.org/keywords/hdl-therapy","display_name":"HDL therapy","score":0.7649999856948853},{"id":"https://openalex.org/keywords/plasma-clearance","display_name":"plasma clearance","score":0.7549999952316284},{"id":"https://openalex.org/keywords/protein-engineering","display_name":"protein engineering","score":0.4959999918937683},{"id":"https://openalex.org/keywords/fusion-protein","display_name":"fusion protein","score":0.8730000257492065},{"id":"https://openalex.org/keywords/cholesterol-efflux","display_name":"cholesterol efflux","score":0.7429999709129333},{"id":"https://openalex.org/keywords/lcat","display_name":"lecithin:cholesterol acyltransferase","score":0.9760000109672546},{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.8619999885559082},{"id":"https://openalex.org/keywords/ldl-receptor-deficient-mice","display_name":"LDL receptor-deficient mice","score":0.7929999828338623},{"id":"https://openalex.org/keywords/atherosclerotic-plaque-stabilization","display_name":"atherosclerotic plaque stabilization","score":0.7770000100135803}],"concepts":[{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.8198344707489014},{"id":"https://openalex.org/C62746215","wikidata":"https://www.wikidata.org/wiki/Q14890615","display_name":"Apolipoprotein B","level":3,"score":0.7459818124771118},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.6943244934082031},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.6433318853378296},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6076877117156982},{"id":"https://openalex.org/C2780541478","wikidata":"https://www.wikidata.org/wiki/Q410020","display_name":"High-density lipoprotein","level":3,"score":0.4950477182865143},{"id":"https://openalex.org/C2779564620","wikidata":"https://www.wikidata.org/wiki/Q241595","display_name":"Lecithin","level":2,"score":0.4495696425437927},{"id":"https://openalex.org/C123894998","wikidata":"https://www.wikidata.org/wiki/Q425158","display_name":"Fusion protein","level":4,"score":0.42289304733276367},{"id":"https://openalex.org/C110459506","wikidata":"https://www.wikidata.org/wiki/Q7318217","display_name":"Reverse cholesterol transport","level":4,"score":0.41203704476356506},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.39262086153030396},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.37536942958831787},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3592146635055542},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3272184431552887},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.24154984951019287},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1680719256401062},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008264","descriptor_name":"Macrophages","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008264","descriptor_name":"Macrophages","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008264","descriptor_name":"Macrophages","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011108","descriptor_name":"Polymers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011973","descriptor_name":"Receptors, LDL","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016632","descriptor_name":"Apolipoprotein A-I","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D016632","descriptor_name":"Apolipoprotein A-I","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018345","descriptor_name":"Mice, Knockout","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1097/fjc.0b013e31815ed0b9","doi":"https://doi.org/10.1097/fjc.0b013e31815ed0b9","is_oa":false,"landing_page_url":"https://doi.org/10.1097/fjc.0b013e31815ed0b9","pdf_url":null,"source":{"id":"https://openalex.org/S61167191","display_name":"Journal of Cardiovascular Pharmacology","issn_l":"0160-2446","issn":["0160-2446","1533-4023"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cardiovascular Pharmacology","raw_type":"journal-article"},{"id":"pmid:18287885","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18287885","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of cardiovascular pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:publications/2fb807f0-4128-11dd-a60c-000ea68e967b","doi":null,"is_oa":false,"landing_page_url":"https://pure.au.dk/portal/en/publications/2fb807f0-4128-11dd-a60c-000ea68e967b","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Graversen, J H, Laurberg, J M, Andersen, M H, Falk, E, Nieland, J, Christensen, J, Etzerodt, M, Th\u00f8gersen, H C & Moestrup, S K 2008, 'Trimerization of apolipoprotein A-I retards plasma clearance and preserves antiatherosclerotic properties', Journal of Cardiovascular Pharmacology, vol. 51, no. 2, pp. 170-177.","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W1569219037","https://openalex.org/W1596523068","https://openalex.org/W1994106242","https://openalex.org/W1996956472","https://openalex.org/W2012842874","https://openalex.org/W2013429267","https://openalex.org/W2014526613","https://openalex.org/W2015642624","https://openalex.org/W2018409369","https://openalex.org/W2035556953","https://openalex.org/W2049643539","https://openalex.org/W2069215018","https://openalex.org/W2080566499","https://openalex.org/W2086116966","https://openalex.org/W2095507444","https://openalex.org/W2099450181","https://openalex.org/W2101687481","https://openalex.org/W2101763835","https://openalex.org/W2115220026","https://openalex.org/W2130470304","https://openalex.org/W2139836755","https://openalex.org/W2141907642","https://openalex.org/W2155588817","https://openalex.org/W2156394096","https://openalex.org/W2182177165","https://openalex.org/W2287674959","https://openalex.org/W2419026049","https://openalex.org/W2579866937"],"related_works":["https://openalex.org/W2005618017","https://openalex.org/W102362783","https://openalex.org/W2127960660","https://openalex.org/W2091284732","https://openalex.org/W2047355930","https://openalex.org/W2159313191","https://openalex.org/W2215181089","https://openalex.org/W4289767766","https://openalex.org/W2348831894","https://openalex.org/W7095080194"],"abstract_inverted_index":{"An":[0],"increased":[1],"plasma":[2,92],"level":[3],"of":[4,17,31,61,107,112,121,131],"the":[5,15,58],"major":[6,44],"high-density":[7],"lipoprotein":[8,126],"(HDL)":[9],"component,":[10],"apolipoprotein":[11],"A-I":[12],"(apoA-I)":[13],"is":[14,33,42,139],"aim":[16],"several":[18],"therapeutic":[19,144],"strategies":[20],"for":[21,46,146],"combating":[22],"atherosclerotic":[23,147],"disease.":[24],"HDL":[25],"therapy":[26],"by":[27],"direct":[28],"intravenous":[29,85],"administration":[30,130],"apoA-I":[32,56,71,101,134],"a":[34,38,43,67,141],"plausible":[35],"way;":[36],"however,":[37],"fast":[39],"renal":[40],"filtration":[41],"obstacle":[45],"this":[47],"approach.":[48],"Using":[49],"protein":[50,76],"engineering":[51],"technology,":[52],"we":[53],"have":[54],"fused":[55],"to":[57,96],"trimerization":[59],"domain":[60],"human":[62],"tetranectin":[63],"and":[64,79,84,118],"thus":[65],"constructed":[66],"high-mass":[68,133],"recombinant":[69,74,132],"trimeric":[70],"variant.":[72],"The":[73],"fusion":[75],"was":[77,102],"stable":[78],"expressed":[80],"well;":[81],"upon":[82],"purification":[83],"injection":[86],"into":[87],"mice,":[88],"it":[89],"exhibited":[90],"prolonged":[91],"retention":[93],"time":[94],"compared":[95],"wild":[97],"type":[98],"apoA-I.":[99],"Trimeric":[100],"biologically":[103],"active":[104],"in":[105,123],"terms":[106],"promoting":[108],"cholesterol":[109,114,116],"efflux,":[110],"stimulation":[111],"lecithin":[113],"acyltransferase-mediated":[115],"esterification,":[117],"reducing":[119],"progression":[120],"atherosclerosis":[122],"cholesterol-fed":[124],"low-density":[125],"receptor-deficient":[127],"mice.":[128],"Direct":[129],"analogues":[135],"with":[136],"retarded":[137],"clearance":[138],"therefore":[140],"potential":[142],"novel":[143],"approach":[145],"plaque":[148],"stabilization.":[149]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}